跳至主要内容
临床试验/NL-OMON48892
NL-OMON48892招募中不适用

Thoracoscopic surgical versus catheter ablation approaches for primary treatment of persistent atrial fibrillation - APPROACH AF

Academisch Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age is between 18 and 80 years.
  • - Persistent AF as defined following the ESC 2016 Guidelines, evidenced by 1)
  • ongoing AF on the ECG or 2) documentation of AF necessitating cardioversion.
  • - AF documented by ECG or Holter < 1 year ago.
  • - At least one class I or III anti-arrhythmic drug in standard dosage has
  • failed or is not tolerated.
  • - Left atrial volume index <40 ml/m2

排除标准

  • - Prior intervention (catheter ablation or minimally-invasive thoracoscopic
  • ablation) for AF.
  • - AF is secondary to electrolyte imbalance, thyroid disease or other reversible
  • or non-cardiovascular causes.
  • - Paroxysmal AF
  • - Long standing Persistent AF, defined as AF continuously present for longer
  • than 1 year.
  • - Body mass index >35kg/m2

研究者

相似试验

Thoracoscopic surgical versus catheter ablation... | 临床试验